Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
Scientific Reports|April 30, 2025
Galleria mellonella as a drug discovery model to study oxidative stressFred Jonathan Edzeamey, Zenouska Ramchunder, Ronan R McCarthy, et al.
Frontiers in Pharmacology|February 21, 2024
Emerging antioxidant therapies in Friedreich's ataxiaFred Jonathan Edzeamey, Zenouska Ramchunder, Charareh Pourzand, et al.
Npj Metabolic Health and Disease|August 5, 2026
Dual SGLT1/2 inhibition with sotagliflozin improves cardiac function and metabolism in type 2 diabetic miceMegan Young, Sanushi Dambure, Fenn Cullen, et al.
Drug Discovery Today|March 18, 2026
Deciphering the missing links between Friedreich ataxia and multiple sclerosis for targeted drug developmentFaith A A Kwa, Sara Anjomani-Virmouni, Zenouska Ramchunder, et al.
Plos One|June 2, 2026
Metabolomics-constrained modelling reveals dominant oxidative metabolism in the Egyptian fruit bat myocardiumAnja Karlstaedt, Fenn Cullen, Rosie Drinkwater, et al.
Redox Report : Communications in Free Radical Research|May 15, 2025
Therapeutic combination of L-ascorbic acid, N-acetylcysteine, and dimethyl fumarate in Friedreich's ataxia: insights from in vitro modelsFred Jonathan Edzeamey, Zenouska Ramchunder, Adamo Valle Gómez, et al.
Diabetes, Obesity & Metabolism|August 20, 2025
Binding kinetics, bias, receptor internalization and effects on insulin secretion in vitro and in vivo of a novel GLP-1R/GIPR dual agonist, HISHS-2001Yusman Manchanda, Ben Jones, Gaelle Carrat, et al.
Biorxiv : the Preprint Server for Biology|January 27, 2025
Binding Kinetics, Bias, Receptor Internalization and Effects on Insulin Secretion in vitro and in vivo of a Novel GLP-1R/GIPR Dual Agonist, HISHS-2001Yusman Manchanda, Ben Jones, Gaelle Carrat, et al.
Science Signaling|July 2, 2024
Engineered mini-G proteins block the internalization of cognate GPCRs and disrupt downstream intracellular signalingYusman Manchanda, Liliane ElEid, Affiong I Oqua, et al.
Iscience|July 1, 2026
Dysregulation of sphingolipid-metabolizing enzymes in Friedreich's ataxia: In vitro and in vivo insights into therapeutic targetingZenouska Ramchunder, Ester Kalef-Ezra, Saqlain Suleman, et al.
Pageof 2